source stringlengths 2 222 | date stringlengths 19 19 | url stringlengths 22 853 ⌀ | text stringlengths 0 10k ⌀ | title stringlengths 0 701 | context_id stringlengths 1 9 | document_id stringclasses 2
values | document_type stringclasses 2
values |
|---|---|---|---|---|---|---|---|
Zacks Investment Research | 2022-01-03 16:04:03 | https://www.zacks.com/stock/news/1846657/earnings-preview-accolade-accd-q3-earnings-expected-to-decline | Accolade (ACCD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. | Earnings Preview: Accolade (ACCD) Q3 Earnings Expected to Decline | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-12-16 18:30:09 | https://seekingalpha.com/article/4475643-accolade-impresses-with-revenue-growth-but-faces-operating-losses | Accolade went public in July 2020, raising $220 million in a U.S. IPO. The firm provides a healthcare information platform for enterprises and end users. | Accolade Impresses With Revenue Growth But Faces Operating Losses | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-12-16 08:00:00 | https://www.globenewswire.com/news-release/2021/12/16/2353558/0/en/Accolade-to-Announce-Fiscal-Third-Quarter-2022-Financial-Results.html | SEATTLE, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced that it will release fiscal third quarter 2022 financial results on Monday, January 10, 2022, after the market closes. In conjunction, the company w... | Accolade to Announce Fiscal Third Quarter 2022 Financial Results | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-10-18 11:41:00 | https://seekingalpha.com/article/4460387-accolade-may-add-to-my-position | Accolade has seen continued growth this year. | Accolade: I May Add To My Position | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
PRNewsWire | 2021-10-12 09:01:00 | https://www.prnewswire.com/news-releases/accolade-brings-wellrights-corporate-wellness-programs-into-its-partner-ecosystem-301397545.html | SEATTLE, Oct. 12, 2021 /PRNewswire/ -- Accolade (Nasdaq: ACCD), a healthcare provider serving millions of people and their families, announced today that WellRight, the provider of the nation's most holistic and comprehensive corporate well-being platform, has joined the company's trusted partner ecosystem. Accolade us... | Accolade Brings WellRight's Corporate Wellness Programs into its partner ecosystem | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-10-07 23:07:06 | https://seekingalpha.com/article/4458972-accolade-inc-accd-ceo-rajeev-singh-on-q2-2022-results-earnings-call-transcript | Accolade, Inc. (ACCD) CEO Rajeev Singh on Q2 2022 Results - Earnings Call Transcript | Accolade, Inc. (ACCD) CEO Rajeev Singh on Q2 2022 Results - Earnings Call Transcript | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-10-07 20:10:31 | https://www.zacks.com/stock/news/1807941/accolade-accd-reports-q2-loss-tops-revenue-estimates | Accolade (ACCD) delivered earnings and revenue surprises of 4.44% and 4.04%, respectively, for the quarter ended August 2021. Do the numbers hold clues to what lies ahead for the stock? | Accolade (ACCD) Reports Q2 Loss, Tops Revenue Estimates | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-10-07 16:05:00 | https://www.globenewswire.com/news-release/2021/10/07/2310814/0/en/Accolade-Announces-Results-for-Fiscal-Second-Quarter-2022.html | SEATTLE, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2021. | Accolade Announces Results for Fiscal Second Quarter 2022 | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-09-30 16:28:21 | https://www.zacks.com/stock/news/1803414/earnings-preview-accolade-accd-q2-earnings-expected-to-decline | Accolade (ACCD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. | Earnings Preview: Accolade (ACCD) Q2 Earnings Expected to Decline | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GeekWire | 2021-09-22 13:02:58 | https://www.geekwire.com/2021/accolade-doubles-personalized-mental-health-services-new-offerings/ | Health benefits platform company Accolade is expanding its offerings to add two personalized services with an emphasis on mental health, the company announced Tuesday. | Accolade doubles down on personalized mental health services with new offerings | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
PRNewsWire | 2021-09-21 12:01:00 | https://www.prnewswire.com/news-releases/accolade-introduces-new-healthcare-category-personalized-healthcare-301381697.html | SEATTLE, Sept. 21, 2021 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD), the company that provides millions of people and their families with exceptional healthcare, today introduced Personalized Healthcare, a new category that enables a nationally scalable model of value-based care to meet the quadruple aim. | Accolade introduces new healthcare category: Personalized Healthcare | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
PRNewsWire | 2021-09-20 14:23:00 | https://www.prnewswire.com/news-releases/accolade-invites-media-investors-and-general-public-to-opening-of-evolve21-301380727.html | SEATTLE, Sept. 20, 2021 /PRNewswire/ -- WHAT: Accolade, Inc. (Nasdaq: ACCD) the company that provides millions of people and their families with exceptional healthcare will be making an announcement during the opening keynotes Evolve21, the company's annual customer event being held virtually from September... | Accolade Invites Media, Investors and General Public to Opening of Evolve21 | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Schaeffers Research | 2021-09-17 10:45:04 | https://www.schaeffersresearch.com/content/news/2021/09/17/accolade-stock-inches-higher-after-baird-upgrade | Accolade Inc (NASDAQ:ACCD) is up 0.7% at $45.31 this morning, after Baird upgraded the healthcare technology name to "outperform" from "neutral. | Accolade Stock Inches Higher After Baird Upgrade | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-09-07 16:15:00 | https://www.globenewswire.com/news-release/2021/09/07/2292921/0/en/Accolade-to-Participate-in-Upcoming-Investor-Conferences.html | SEATTLE, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming investor conferences: | Accolade to Participate in Upcoming Investor Conferences | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-08-17 10:39:17 | https://www.zacks.com/stock/news/1782681/new-strong-sell-stocks-for-august-17th | ACCD, CHRS, ELVT, FLGT, and GSHD have been added to the Zacks Rank #5 (Strong Sell) List on August 17, 2021. | New Strong Sell Stocks for August 17th | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-08-10 08:00:00 | https://www.globenewswire.com/news-release/2021/08/10/2277892/0/en/Accolade-to-Participate-in-the-41st-Annual-Canaccord-Genuity-Growth-Conference.html | SEATTLE, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the 41st Annual Canaccord Genuity Growth Conference, including a presentation on Thursday, August 12, 2021 at 11:00 a.m. E.T. An audio webcast a... | Accolade to Participate in the 41st Annual Canaccord Genuity Growth Conference | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-07-12 10:06:26 | https://www.zacks.com/stock/news/1760177/new-strong-sell-stocks-for-july-12th | ACCD, CMTL, HEXO, NTRB, and GP have been added to the Zacks Rank #5 (Strong Sell) List on July 12, 2021 | New Strong Sell Stocks for July 12th | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-07-08 23:39:08 | https://seekingalpha.com/article/4438394-accolade-inc-accd-ceo-rajeev-singh-on-q1-2022-results-earnings-call-transcript | Accolade, Inc. (ACCD) CEO Rajeev Singh on Q1 2022 Results - Earnings Call Transcript | Accolade, Inc. (ACCD) CEO Rajeev Singh on Q1 2022 Results - Earnings Call Transcript | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-07-08 16:05:00 | https://www.globenewswire.com/news-release/2021/07/08/2260227/0/en/Accolade-Announces-Results-for-Fiscal-First-Quarter-2022.html | SEATTLE, July 08, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced financial results for the fiscal first quarter ended May 31, 2021. | Accolade Announces Results for Fiscal First Quarter 2022 | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-07-01 15:47:05 | https://www.zacks.com/stock/news/1756808/will-accolade-accd-report-negative-earnings-next-week-what-you-should-know | Accolade (ACCD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. | Will Accolade (ACCD) Report Negative Earnings Next Week? What You Should Know | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-06-09 16:15:00 | https://www.globenewswire.com/news-release/2021/06/09/2244772/0/en/Accolade-Completes-Acquisition-of-PlushCare.html | SEATTLE, June 09, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced it has completed the acquisition of PlushCare, a leading provider of virtual primary care and mental health treatment. Together with its expert medi... | Accolade Completes Acquisition of PlushCare | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-06-04 09:46:12 | https://www.zacks.com/stock/news/1654761/booming-telehealth-market-lures-more-ipos-and-ma-deals | To make the most of the booming telehealth industry, players are coming up with IPOs and resorting to mergers and acquisitions. | Booming Telehealth Market Lures More IPOs and M&A Deals | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
PRNewsWire | 2021-06-03 17:00:00 | https://www.prnewswire.com/news-releases/betsy-nabel-and-jeff-brodsky-join-accolade-board-of-directors-301305639.html | SEATTLE, June 3, 2021 /PRNewswire/ -- Accolade (Nasdaq: ACCD), the company reinventing healthcare, today announced a series of changes to its board of directors that will bolster the board with significant healthcare and human resources expertise. Incoming board member Elizabeth ("Betsy") Nabel, M.D. | Betsy Nabel and Jeff Brodsky join Accolade Board of Directors | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-06-01 06:00:00 | https://www.globenewswire.com/news-release/2021/06/01/2239269/0/en/Accolade-to-Participate-in-Upcoming-Investor-Conferences.html | SEATTLE, June 01, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming investor conferences: | Accolade to Participate in Upcoming Investor Conferences | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-05-17 10:32:14 | https://www.zacks.com/stock/news/1565254/new-strong-sell-stocks-for-may-17th | ACCD, CEVA, FCEL, GO, and IIPR have been added to the Zacks Rank #5 (Strong Sell) List on May 17, 2021 | New Strong Sell Stocks for May 17th | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-05-10 11:00:00 | https://www.globenewswire.com/news-release/2021/05/10/2226482/0/en/Accolade-to-Participate-in-Upcoming-Investor-Conferences.html | SEATTLE, May 10, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming investor conferences: | Accolade to Participate in Upcoming Investor Conferences | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-05-08 20:20:05 | https://seekingalpha.com/article/4426128-accolade-inc-accd-ceo-rajeev-singh-on-q4-2021-results-earnings-call-transcript | Accolade, Inc. (ACCD) CEO Rajeev Singh on Q4 2021 Results - Earnings Call Transcript | Accolade, Inc. (ACCD) CEO Rajeev Singh on Q4 2021 Results - Earnings Call Transcript | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-05-05 19:03:00 | https://www.globenewswire.com/news-release/2021/05/05/2223993/0/en/CORRECTION-Accolade-Announces-Results-for-Fiscal-Fourth-Quarter-and-Full-Year-2021.html | SEATTLE, May 05, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Accolade, Inc. (NASDAQ: ACCD) please note that the entire Consolidated Statements of Operations (unaudited) table has been replaced. The corrected release follows: | CORRECTION -- Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2021 | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GeekWire | 2021-04-23 07:00:36 | https://www.geekwire.com/2021/health-benefits-platform-accolade-acquire-virtual-primary-care-startup-plushcare-450m-deal/ | The news: Seattle-based health benefits platform Accolade will pay up to $450 million to acquire PlushCare, a Bay Area-based startup that offers virtual primary care. | Health benefits platform Accolade to acquire virtual primary care startup PlushCare in $450M deal | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-04-23 07:00:00 | https://www.globenewswire.com/news-release/2021/04/23/2215894/0/en/Accolade-to-Acquire-PlushCare.html | SEATTLE, April 23, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced it has signed a definitive agreement to acquire PlushCare, a leading provider of virtual primary care and mental health treatment. Together, the tw... | Accolade to Acquire PlushCare | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-04-06 15:47:40 | https://seekingalpha.com/article/4417871-accolade-interesting-and-solid-healthcare-play | Accolade has seen solid growth throughout the second half of 2020, now accompanied by some margin improvements as well. | Accolade: Interesting And Solid Healthcare Play | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-03-25 04:29:00 | https://www.globenewswire.com/news-release/2021/03/25/2199048/0/en/Accolade-Announces-Pricing-of-250-Million-Convertible-Senior-Notes-Offering.html | SEATTLE, March 25, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) (“Accolade”) announced the pricing of $250 million aggregate principal amount of 0.50% convertible senior notes due 2026 (the “Notes”) in a private placement (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Secur... | Accolade Announces Pricing of $250 Million Convertible Senior Notes Offering | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-03-23 16:03:00 | https://www.globenewswire.com/news-release/2021/03/23/2198079/0/en/Accolade-Announces-Preliminary-Results-for-Fourth-Quarter-and-Full-Year-of-Fiscal-Year-2021.html | SEATTLE, March 23, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) today provided preliminary unaudited financial results for the fiscal fourth quarter and year ended February 28, 2021 (fiscal year 2021). Based on current information, the company expects to report revenue for the fiscal 2021 fourth quarter in th... | Accolade Announces Preliminary Results for Fourth Quarter and Full Year of Fiscal Year 2021 | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-03-23 16:02:00 | https://www.globenewswire.com/news-release/2021/03/23/2198078/0/en/Accolade-Announces-Private-Offering-of-250-Million-Convertible-Notes.html | SEATTLE, March 23, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) (“Accolade”) announced today that it intends to offer, subject to market and other conditions, $250 million aggregate principal amount of convertible senior notes due 2026 (the “Notes”) in a private placement (the “offering”) to qualified institu... | Accolade Announces Private Offering of $250 Million Convertible Notes | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-02-16 08:00:00 | https://www.globenewswire.com/news-release/2021/02/16/2176050/0/en/Accolade-to-Participate-in-Upcoming-Investor-Conferences.html | SEATTLE, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the following upcoming investor conferences: | Accolade to Participate in Upcoming Investor Conferences | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GeekWire | 2021-01-14 17:34:51 | https://www.geekwire.com/2021/health-benefits-platform-accolade-will-pay-460m-acquire-telemedicine-startup-2nd-md/ | Seattle-based Accolade announced Thursday that it will pay $460 million acquire 2nd. | Health benefits platform Accolade will pay $460M to acquire telemedicine startup 2nd.MD | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2021-01-14 17:23:45 | https://www.marketwatch.com/story/accolade-agrees-to-buy-medical-expert-company-for-460-million-2021-01-14 | Accolade Inc. said late Thursday it has agreed to buy Innovation Specialists LLC, which does business as 2nd.MD, a "leading" expert medical opinion and medical decision support company based in Houston, for $460 million. The deal is expected to close by the end of February, and under the terms of the agreement, Accolad... | Accolade agrees to buy medical-expert company for $460 million | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-01-14 16:50:00 | https://www.globenewswire.com/news-release/2021/01/14/2159074/0/en/Accolade-to-Acquire-2nd-MD.html | The addition of 2nd.MD's Expert Medical Opinion services to Accolade's portfolio of high-touch, technology-enabled health and benefits solutions expands Accolade's clinical capabilities and creates the market's most comprehensive, integrated healthcare navigation experience. | Accolade to Acquire 2nd.MD | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
CNBC | 2021-01-14 16:35:09 | https://www.cnbc.com/2021/01/14/healthtech-firm-accolade-is-buying-telemedicine-start-up-2ndmd-for-460-million-sources-say.html | Just as the digitization of finance has attracted billions in investment and a flurry of M&A, health tech has seen a surge in interest during the pandemic. | Healthtech firm Accolade is buying telemedicine start-up 2nd.MD for $460 million, sources say | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-01-12 15:14:50 | https://seekingalpha.com/article/4398596-accolade-inc-bullish-outlook-healthtech-platform-helps-companies-save | Accolade integrates workplace benefits into one platform and helps organizations save on employee healthcare costs through a virtual concierge service. The company launched its IPO in July of 2020 and is presenting strong growth with a positive operational outlook. | Accolade Inc.: Bullish Outlook As Its HealthTech Platform Helps Companies Save | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-01-11 08:00:00 | https://www.globenewswire.com/news-release/2021/01/11/2156216/0/en/Accolade-to-Participate-in-39th-Annual-J-P-Morgan-Healthcare-Conference.html | SEATTLE, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the 39th Annual J.P. Morgan Healthcare Conference, includi... | Accolade to Participate in 39th Annual J.P. Morgan Healthcare Conference | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-01-07 22:56:01 | https://seekingalpha.com/article/4397860-accolade-inc-accd-ceo-rajeev-singh-on-q3-2021-results-earnings-call-transcript | Accolade, Inc. (ACCD) CEO Rajeev Singh on Q3 2021 Results - Earnings Call Transcript | Accolade, Inc. (ACCD) CEO Rajeev Singh on Q3 2021 Results - Earnings Call Transcript | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-01-07 16:05:00 | https://www.globenewswire.com/news-release/2021/01/07/2155241/0/en/Accolade-Announces-Results-for-Fiscal-Third-Quarter-2021.html | SEATTLE, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced financial results for the fiscal third quarter ended November ... | Accolade Announces Results for Fiscal Third Quarter 2021 | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2020-12-23 08:00:00 | https://www.globenewswire.com/news-release/2020/12/23/2149964/0/en/Accolade-to-Announce-Fiscal-Third-Quarter-2021-Financial-Results.html | SEATTLE, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced that it will release fiscal third quarter 2021 financial resul... | Accolade to Announce Fiscal Third Quarter 2021 Financial Results | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2020-12-17 05:00:00 | https://www.globenewswire.com/news-release/2020/12/17/2146745/0/en/Accolade-to-Participate-in-William-Blair-Healthcare-2021-Focus-List-Event.html | SEATTLE, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the William Blair Healthcare 2021 Focus List Event, includ... | Accolade to Participate in William Blair Healthcare 2021 Focus List Event | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2020-11-20 08:00:00 | https://www.globenewswire.com/news-release/2020/11/20/2130930/0/en/Accolade-to-Participate-in-the-Piper-Sandler-32nd-Annual-Virtual-Healthcare-Conference.html | SEATTLE, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conferenc... | Accolade to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2020-10-28 08:30:00 | https://www.globenewswire.com/news-release/2020/10/28/2115925/0/en/Accolade-to-Participate-in-the-29th-Annual-Credit-Suisse-Healthcare-Conference.html | SEATTLE, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the virtual 29th Annual Credit Suisse Healthcare Conferenc... | Accolade to Participate in the 29th Annual Credit Suisse Healthcare Conference | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-08-17 09:14:12 | https://seekingalpha.com/article/4369144-accolade-still-interesting | Accolade has seen a solid first quarter since it went public. The company is expecting a softer second quarter, yet sees a growth acceleration in the quarters to follow. | Accolade: Still Very Interesting | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-08-14 10:57:52 | https://seekingalpha.com/article/4368731-accolade-inc-2021-q1-results-earnings-call-presentation | The following slide deck was published by Accolade, Inc. in conjunction with their 2021 Q1 earnings call.. | Accolade, Inc. 2021 Q1 - Results - Earnings Call Presentation | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-08-13 23:14:08 | https://seekingalpha.com/article/4368638-accolades-accd-ceo-rajeev-singh-on-q1-2021-results-earnings-call-transcript | Accolade, Inc. (NASDAQ:ACCD) Q1 2021 Earnings Conference Call August 13, 2020 5:00 PM ET Company Participants Rajeev Singh – Chief Executive Officer Steve Barnes – Chief Financial Officer Conference Call Participants Bob Jones – Goldman Sachs Ricky Goldwasser – Morgan Stanley Michael Cherny – Bank of America Sean Wiela... | Accolade's (ACCD) CEO Rajeev Singh on Q1 2021 Results - Earnings Call Transcript | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-13 20:03:00 | https://finance.yahoo.com/news/accolade-announces-results-fiscal-first-200300325.html | * Fiscal first quarter 2021 revenue of $35.9 million, a 25% increase compared to fiscal first quarter 2020 revenue of $28.8 million, driven primarily by strength in new customer adds across segments and offerings * Launched pilot with Defense Health Agency, our first customer in the federal government sector * Prov... | Accolade Announces Results for Fiscal First Quarter 2021 | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-27 13:48:00 | https://seekingalpha.com/article/4361055-significant-market-shift-to-value-stocks-is-bound-to-happen | A major shift into tech/growth stocks occurred due to the COVID-19 pandemic with the Nasdaq being up 18% YTD. I anticipate that this trend will reverse soon. | A Significant Market Shift To Value Stocks Is Bound To Happen | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-07-27 13:00:00 | https://finance.yahoo.com/news/accolade-announce-fiscal-first-quarter-130000199.html | SEATTLE, July 27, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced that it will release fiscal first quarter 2021 financial resul... | Accolade to Announce Fiscal First Quarter 2021 Financial Results | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-25 08:52:35 | https://seekingalpha.com/article/4360800-u-s-ipo-week-ahead-tax-software-leads-diverse-7-ipo-week | Seven IPOs and one SPAC plan to raise $2.1 billion in the week ahead, led by tax software provider Vertex. | U.S. IPO Week Ahead: Tax Software Leads A Diverse 7-IPO Week | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-07-18 01:04:00 | https://finance.yahoo.com/m/7504ff19-5934-30ab-b993-aed793ba9de4/mednax%2C-accolade-see-activist.html | Starboard Value increased its position in pediatric and neonatal health-services firm Mednax. Carrick Management Partners disclosed an initial investment of 3,508,278 shares in Accolade, a newly public workplace health-benefits manager. | Mednax, Accolade See Activist Actions | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-07-07 18:11:00 | https://finance.yahoo.com/news/accolade-announces-closing-initial-public-181100849.html | Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced the closing of its initial public offering of 11,526,134 shares of its common stock, inclusive of the ful... | Accolade Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-05 03:47:23 | https://seekingalpha.com/article/4356956-accolade-interesting-tech-and-healthcare-offering | Accolade operates at the intersection of tech and healthcare, an interesting environment to operate in. I see the potential for the business as the company has | Accolade - Interesting Tech And Healthcare Offering | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-03 14:28:59 | https://seekingalpha.com/article/4356911-u-s-ipo-weekly-recap-3-ipos-close-out-2q-in-shortened-holiday-week | Three IPOs raised $2.3 billion this past week, led by Dun & Bradstreet's billion-dollar deal. All three IPOs upsized their deals and priced above the range. Lem | U.S. IPO Weekly Recap: 3 IPOs Close Out The 2Q In Shortened Holiday Week | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-07-02 03:03:00 | https://finance.yahoo.com/news/accolade-announces-pricing-initial-public-030300773.html | Accolade, Inc. ("Accolade"), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced the pricing of its initial public offering of 10,022,726 shares of its common stock at a price to the publi... | Accolade Announces Pricing of Initial Public Offering | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-06-27 11:03:22 | https://seekingalpha.com/article/4355972-u-s-ipo-week-ahead-dun-bradstreet-returns-to-public-market-in-shortened-4-ipo-week | Four IPOs are expected to raise $2 billion before the Fourth of July, led by commercial data analytics provider Dun & Bradstreet. Insurtech startup Lemonade pla | U.S. IPO Week Ahead: Dun & Bradstreet Returns To Public Market In Shortened 4 IPO Week | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-06-24 20:53:20 | https://seekingalpha.com/article/4355508-ipo-update-accolade-proposes-terms-for-u-s-ipo | Accolade intends to raise $175 million in a U.S. IPO. The firm provides a healthcare management and relationship platform to enterprises. ACCD has grown revenue | IPO Update: Accolade Proposes Terms For U.S. IPO | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SEEKINGALPHA | 2020-03-05 19:03:49 | https://seekingalpha.com/article/4329995-accolade-seeks-100-million-in-u-s-ipo | Accolade has filed to raise $100 million in an IPO, although the final figure may differ. The firm has developed an integrated healthcare and wellness platform | Accolade Seeks $100 Million In U.S. IPO | ACCD | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-05-04 21:17:25 | https://www.zacks.com/stock/news/2090578/acco-brands-acco-surpasses-q1-earnings-and-revenue-estimates | Acco Brands (ACCO) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.11 per share a year ago. | Acco Brands (ACCO) Surpasses Q1 Earnings and Revenue Estimates | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-04-18 11:26:00 | https://www.zacks.com/stock/news/2080428/analysts-estimate-acco-brands-acco-to-report-a-decline-in-earnings-what-to-look-out-for | Acco (ACCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. | Analysts Estimate Acco Brands (ACCO) to Report a Decline in Earnings: What to Look Out for | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-03-28 11:29:24 | https://www.zacks.com/stock/news/2071342/is-the-options-market-predicting-a-spike-in-acco-brands-acco-stock | Investors need to pay close attention to ACCO Brands (ACCO) stock based on the movements in the options market lately. | Is the Options Market Predicting a Spike in ACCO Brands (ACCO) Stock? | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-02-24 14:41:07 | https://seekingalpha.com/article/4581836-acco-brands-corporation-acco-q4-2022-earnings-call-transcript | ACCO Brands Corporation (NYSE:ACCO ) Q4 2022 Earnings Conference Call February 24, 2023 8:30 AM ET Company Participants Chris McGinnis - Investor Relations Boris Elisman - Chairman and Chief Executive Officer Tom Tedford - President and Chief Operating Officer Deb O'Connor - Executive Vice President and Chief Financial... | ACCO Brands Corporation (ACCO) Q4 2022 Earnings Call Transcript | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-23 20:19:11 | https://www.zacks.com/stock/news/2058485/acco-brands-acco-misses-q4-earnings-and-revenue-estimates | Acco (ACCO) delivered earnings and revenue surprises of -3.03% and 1.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? | Acco Brands (ACCO) Misses Q4 Earnings and Revenue Estimates | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-06 08:17:05 | https://www.zacks.com/stock/news/2050182/5-promising-price-to-book-value-stocks-to-buy-in-february | The P/B ratio helps to identify low-priced stocks that have high growth prospects. Deutsche Bank Aktiengesellschaft (DB), Signet Jewelers (SIG), Phillips 66 (PSX), Acco Brands Corporation (ACCO) and Sterling Infrastructure (STRL) are some such stocks. | 5 Promising Price-to-Book Value Stocks to Buy in February | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2023-02-03 09:15:00 | https://www.businesswire.com/news/home/20230203005113/en/ACCO-Brands-Corporation-Announces-Fourth-Quarter-and-Full-Year-2022-Earnings-Webcast/ | LAKE ZURICH, Ill.--( BUSINESS WIRE )--ACCO Brands Corporation (NYSE: ACCO) today announced that it will release its fourth quarter and full year 2022 earnings after the market close on February 23, 2023. The Company will host a conference call and webcast to discuss the results on February 24 at 8:30 a.m. EST. The webc... | ACCO Brands Corporation Announces Fourth Quarter and Full Year 2022 Earnings Webcast | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-01-31 09:30:33 | https://www.zacks.com/stock/news/2046802/add-value-to-your-investment-with-these-4-low-p-cf-stocks | Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Signet (SIG), NRG Energy (NRG), ACCO Brands (ACCO) and Sterling Infrastructure (STRL) boast low P/CF ratios. | Add Value to Your Investment With These 4 Low P/CF Stocks | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-12-13 12:02:12 | https://www.zacks.com/stock/news/2028334/new-strong-sell-stocks-for-december-13th | ACCO, ASIX and AIZ have been added to the Zacks Rank #5 (Strong Sell) List on December 13, 2022. | New Strong Sell Stocks for December 13th | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-12-09 09:47:22 | https://www.zacks.com/stock/news/2027165/new-strong-sell-stocks-for-december-9th | ACCO, BHC and HOUS have been added to the Zacks Rank #5 (Strong Sell) List on December 9, 2022. | New Strong Sell Stocks for December 9th | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2022-12-02 14:36:45 | https://investorplace.com/best-cheap-stocks-under-10-dollars/ | After rising last month due to increased hopes for a slowdown in inflation and a possible easing of Federal Reserve rate hikes, it's unclear whether the stock market as a whole will keep climbing or if another round of volatility is just around the corner. Yet, while uncertainty still runs high, that doesn't necessaril... | The 7 Best Cheap Stocks Under $10 to Buy Now | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-11-08 12:49:02 | https://seekingalpha.com/article/4554863-acco-brands-corporation-acco-ceo-boris-elisman-on-q3-2022-results-earnings-call-transcript | ACCO Brands Corporation (NYSE:ACCO ) Q 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Chris McGinnis - Senior Director, Investor Relations Boris Elisman - Chairman and Chief Executive Officer Deb O'Connor - Executive Vice President and Chief Financial Officer Conference Call Participants... | ACCO Brands Corporation (ACCO) CEO Boris Elisman on Q3 2022 Results - Earnings Call Transcript | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-11-07 20:19:32 | https://www.zacks.com/stock/news/2015104/acco-brands-acco-q3-earnings-and-revenues-surpass-estimates | Acco (ACCO) delivered earnings and revenue surprises of 4.17% and 0.17%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock? | Acco Brands (ACCO) Q3 Earnings and Revenues Surpass Estimates | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-10-27 14:07:27 | https://seekingalpha.com/article/4549937-dividend-challengers-review-acco-brands | Dividend Challengers are stocks that have increased their dividend every year for at least five consecutive years. In this series of articles, I will be reviewing Dividend Challenger stocks and determining whether they are attractive long term buys for investors based on a number of criteria. | Dividend Challengers Review: ACCO Brands | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-10-25 12:02:13 | https://www.zacks.com/stock/news/1996947/is-the-options-market-predicting-a-spike-in-acco-brands-acco-stock | Investors need to pay close attention to ACCO Brands (ACCO) stock based on the movements in the options market lately. | Is the Options Market Predicting a Spike in ACCO Brands (ACCO) Stock? | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-10-20 09:47:20 | https://www.zacks.com/stock/news/1994772/new-strong-sell-stocks-for-october-20th | ACCO, ACH, and BTDPY have been added to the Zacks Rank #5 (Strong Sell) List on October 20, 2022. | New Strong Sell Stocks for October 20th | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-09-29 11:10:12 | https://seekingalpha.com/article/4543814-acco-brands-speculative-buy-on-valuations-despite-high-debt | The near-term revenue and margin growth should be driven by pricing actions, strong back-to-school season, and return to office trends. The gaming industry is facing near term headwinds but long term outlook is good. | ACCO Brands: Speculative Buy On Valuations And Fundamentals Despite High Debt | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-09-26 09:47:18 | https://www.zacks.com/stock/news/1984701/new-strong-sell-stocks-for-september-26th | EGRX, ACCO and ATUS have been added to the Zacks Rank #5 (Strong Sell) List on September 26, 2022. | New Strong Sell Stocks for September 26th | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-09-23 06:52:40 | https://seekingalpha.com/article/4542669-acco-brands-declining-profits-stock-offers-upside | ACCO Brands has had mixed financial results lately, particularly on the bottom line. Investors are likely spooked because of some fundamental weakness and concerns over the broader economy. | ACCO Brands: Even With Declining Profits, Shares Offer Upside | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-08-12 19:42:07 | https://seekingalpha.com/article/4533794-acco-brands-corporations-acco-ceo-boris-elisman-on-q2-2022-results-earnings-call-transcript | ACCO Brands Corporation (NYSE:ACCO ) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Chris McGinnis - Senior Director, Investor Relations Boris Elisman - Chairman and Chief Executive Officer Deb O'Connor - Executive Vice President and Chief Financial Officer Conference Call Participants ... | ACCO Brands Corporation's (ACCO) CEO Boris Elisman on Q2 2022 Results - Earnings Call Transcript | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-08-01 11:37:33 | https://www.zacks.com/stock/news/1961358/analysts-estimate-acco-brands-acco-to-report-a-decline-in-earnings-what-to-look-out-for | Acco (ACCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. | Analysts Estimate Acco Brands (ACCO) to Report a Decline in Earnings: What to Look Out for | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2022-07-14 16:30:00 | https://www.businesswire.com/news/home/20220714005765/en/ACCO-Brands-Corporation-Announces-Second-Quarter-2022-Earnings-Webcast/ | LAKE ZURICH, Ill.--(BUSINESS WIRE)--ACCO Brands Corporation (NYSE: ACCO) today announced that it will release its second quarter 2022 earnings after the market close on August 8, 2022. The Company will host a conference call and webcast to discuss the results on August 9 at 8:30 a.m. EST. The webcast can be accessed th... | ACCO Brands Corporation Announces Second Quarter 2022 Earnings Webcast | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-07-01 10:45:32 | https://www.zacks.com/stock/news/1946721/is-acco-brands-acco-a-worthy-pick-for-value-investors | Is Acco Brands (ACCO) a great pick from the value investor's perspective right now? Read on to know more. | Is Acco Brands (ACCO) a Worthy Pick for Value Investors? | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2022-03-21 14:29:00 | https://www.businesswire.com/news/home/20220321005818/en/ACCO-Brands-Corporation-Announces-Participation-in-Sidoti-Spring-2022-Virtual-Conference-on-March-23-24/ | LAKE ZURICH, Ill.--(BUSINESS WIRE)--ACCO Brands Corporation (NYSE: ACCO) today announced that its management will participate in the Sidoti Spring 2022 Virtual Conference. The company's presentation will be March 24 at 12:15 p.m. EDT. The presentation will be accessible through the Investor Relations section of www.acc... | ACCO Brands Corporation Announces Participation in Sidoti Spring 2022 Virtual Conference on March 23-24 | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-03-12 04:27:02 | https://seekingalpha.com/article/4495063-acco-brands-quality-provider-office-school-products-cheap | ACCO Brands has managed to be relatively consistent in recent years in terms of sales, profits, and cash flows. | ACCO Brands: A Quality Provider Of Name Brand Office And School Products | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-02-16 11:23:11 | https://seekingalpha.com/article/4487451-acco-brands-corporation-acco-ceo-boris-elisman-on-q4-2021-results-earnings-call-transcript | ACCO Brands Corporation (ACCO) CEO Boris Elisman on Q4 2021 Results - Earnings Call Transcript | ACCO Brands Corporation (ACCO) CEO Boris Elisman on Q4 2021 Results - Earnings Call Transcript | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-10-27 13:38:20 | https://seekingalpha.com/article/4462522-acco-brands-corporation-acco-ceo-boris-elisman-on-q3-2021-results-earnings-call-transcript | ACCO Brands Corporation (ACCO) CEO Boris Elisman on Q3 2021 Results - Earnings Call Transcript | ACCO Brands Corporation (ACCO) CEO Boris Elisman on Q3 2021 Results - Earnings Call Transcript | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-10-26 19:45:16 | https://www.zacks.com/stock/news/1817208/acco-brands-acco-q3-earnings-and-revenues-lag-estimates | Acco (ACCO) delivered earnings and revenue surprises of -2.94% and -1.12%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock? | Acco Brands (ACCO) Q3 Earnings and Revenues Lag Estimates | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga | 2021-10-25 11:12:54 | https://www.benzinga.com/news/earnings/21/10/23534729/earnings-preview-acco-brands | ACCO Brands (NYSE:ACCO) is set to give its latest quarterly earnings report on Tuesday, 2021-10-26. Here's what investors need to know before the announcement. | Earnings Preview: ACCO Brands | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-10-19 16:41:23 | https://www.zacks.com/stock/news/1812786/acco-brands-acco-reports-next-week-wall-street-expects-earnings-growth | Acco (ACCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. | Acco Brands (ACCO) Reports Next Week: Wall Street Expects Earnings Growth | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-10-01 12:27:16 | https://www.zacks.com/stock/news/1803850/5-smaller-dividend-payers-with-bright-prospects | Small and mid-caps look attractive today. | 5 Smaller Dividend Payers with Bright Prospects | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-09-23 08:05:00 | https://www.businesswire.com/news/home/20210923005044/en/Kensington-Protects-and-Enhances-Usage-of-Microsoft-Surface-Devices-with-Portfolio-of-Designed-for-Surface-Products/ | SAN MATEO, Calif.--(BUSINESS WIRE)-- #DFS--Kensington announces portfolio of products designed to protect and enhance the usage of Microsoft Surface devices. | Kensington Protects and Enhances Usage of Microsoft Surface Devices with Portfolio of Designed for Surface Products | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-09-09 09:26:06 | https://www.zacks.com/stock/news/1794159/looking-for-value-why-it-might-be-time-to-try-acco-brands-corporation-acco | Acco Brands Corporation (ACCO) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well. | Looking for Value? Why It Might Be Time to Try Acco Brands Corporation (ACCO) | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-09-07 08:10:00 | https://www.businesswire.com/news/home/20210907005202/en/Kensington-Expands-Industry-Leading-Line-of-Laptop-Locks-with-Launch-of-NanoSaver%C2%AE-Laptop-Locks/ | SAN MATEO, Calif.--(BUSINESS WIRE)-- #asus--Kensington launches NanoSaver combination and keyed cable laptop locks supporting the Nano Security Slot on the new generation of compact devices. | Kensington Expands Industry-Leading Line of Laptop Locks with Launch of NanoSaver® Laptop Locks | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-08-06 10:26:00 | https://www.businesswire.com/news/home/20210806005373/en/ACCO-Brands-Corporation-Declares-Quarterly-Dividend/ | LAKE ZURICH, Ill.--(BUSINESS WIRE)--ACCO Brands Corporation (NYSE: ACCO) today announced that its board of directors has declared a quarterly cash dividend of $0.065 per share. The dividend will be paid on September 15, 2021, to stockholders of record as of the close of business on August 27, 2021. About ACCO Brands Co... | ACCO Brands Corporation Declares Quarterly Dividend | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-08-03 12:13:13 | https://www.zacks.com/commentary/1773302/top-ranked-value-stocks-to-buy-for-august-3rd | TPH, FISI, ACCO, and GMS made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 3, 2021 | Top Ranked Value Stocks to Buy for August 3rd | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-07-31 05:20:02 | https://seekingalpha.com/article/4443470-acco-brands-corporation-acco-ceo-boris-elisman-on-q2-2021-results-earnings-call-transcript | ACCO Brands Corporation (ACCO) CEO Boris Elisman on Q2 2021 Results - Earnings Call Transcript | ACCO Brands Corporation (ACCO) CEO Boris Elisman on Q2 2021 Results - Earnings Call Transcript | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-07-28 18:59:36 | https://www.zacks.com/stock/news/1769926/acco-brands-acco-tops-q2-earnings-and-revenue-estimates | Acco (ACCO) delivered earnings and revenue surprises of 59.26% and 8.65%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock? | Acco Brands (ACCO) Tops Q2 Earnings and Revenue Estimates | ACCO | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.